With accumulating evidence supporting the important role of the GP73 in tumorgeneisis and cancer resistance, our study suggests an exciting potential of GP73 in cancer therapy which may help to alleviate the current drug resistance issue. The gene discussed is GOLM1; the disease is cancer.